Showing results (121-130 of 366) with videos related to
Sort By:
Pageof 37
Cancer Research|August 27, 2009
Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688delArcangela De Nicolo, Emilio Parisini, Quan Zhong, et al.JCO Oncology Practice|July 18, 2024
Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic AdenocarcinomaKelsey S Lau-Min, Heather Symecko, Kelsey Spielman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex TestingJudith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.Journal of Genetic Counseling|October 10, 2025
Assessment of barriers to pancreatic cancer surveillance in high-risk individualsGrace G Snyder, Daniel Clay, Sara Karley, et al.The American Journal of Gastroenterology|September 24, 2020
Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni SyndromeBryson W Katona, Jacquelyn Powers, Danielle B McKenna, et al.JCO Precision Oncology|September 13, 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic SequencingDana Farengo Clark, Kara N Maxwell, Jacquelyn Powers, et al.Cancer Medicine|August 31, 2021
Relationship of established risk factors with breast cancer subtypesAnne Marie McCarthy, Tara Friebel-Klingner, Sarah Ehsan, et al.JAMA Oncology|May 27, 2021
Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United StatesSusan M Domchek, Song Yao, Fei Chen, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 14, 2020
Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancerDana Farengo Clark, Scott T Michalski, Rashmi Tondon, et al.Clinical Genetics|February 6, 2020
Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patientsAngela R Bradbury, Brian L Egleston, Linda J Patrick-Miller, et al.Pageof 37